D. B. Sacdalan

Choosing Wisely Philippines: ten low-value or harmful practices that should be avoided in cancer care

D. B. Sacdalan, F. Ting, D. Sacdalan, 2022, Ecancermedicalscience.

A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer.

J. Lucero, D. B. Sacdalan, 2022, Cancer treatment and research communications.

The role of the medical oncologist in the holistic care of patients with cancer in the Philippines

D. B. Sacdalan, F. Ting, D. Sacdalan, 2021, Ecancermedicalscience.

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

D. B. Sacdalan, D. Sacdalan, J. Lucero, 2018, OncoTargets and therapy.

What Will Keep Me Coming Back to the Clinic: Factors Identified by Filipino Colorectal Cancer Patients Seen at a National Academic Referral Center

F. Ting, D. Sacdalan, J. Lucero, 2019, Journal of patient experience.